Life Science Days 2019

High level discussion on the questions: What do life science start-ups and spin-offs have to take into account when dealing with investors? What do investors put attention to in early stage funding?

The Life Science Investment Days were held in Vienna from 7 to 8 November. Jasmin Güngör, investment manager of Hermann Hauser Investment GmbH, spoke on the panel of the Life Science Investment Days at the 8th of November 2019 in Vienna.The discussion was about „Early Stage Funding – Challenges and Pitfalls“. Other panelists were Felix Faltin (Speedinvest), Astrid Woollard (Scytale Ventures) and Jaromir Zahradka (i&i).

For more information please click here.

„We are a supporter of science based entrepreneurship and life science is one of the topics that are important for our I.E.C.T. programmes as well as our investment arm. Hermann invests mainly in basic technologies like DNA sequencing. One of the most prominent examples was Solexa that was sold for 600 Mio. EUR to Illumina. Hermann Hauser Investment GmbH is currently shareholder of the Italian Immagina Biotechnology that works in the field of RNA sequencing.”

JASMIN GÜNGÖR, INVESTMENT MANAGERIN

Life Science Days 2019

High level discussion on the questions: What do life science start-ups and spin-offs have to take into account when dealing with investors? What do investors put attention to in early stage funding?

News from I.E.C.T. – more in the Newsroom

Stay up to date!